Niagen Bioscience, Inc. (NAGE) Institutional Ownership

Ownership Summary

According to SEC filings for the period ending September 2025, Niagen Bioscience, Inc. (NASDAQ:NAGE) is held by 160 institutional firms.

• These investors collectively held 39.7% of the company's total shares outstanding in September 2025, up from 36.9% in June 2025.
• Institutional share ownership changed by 14.14% QoQ, while the number of institutional owners saw an increase of 75.82% YoY.
• Of these 160 institutional investors, 93 increased their holdings in Niagen Bioscience, while 46 of them reduced positions, and 21 investors maintained their exposure.
• The total number of shares held by institutions in Niagen Bioscience increased to 31.69Mn as of September 2025, a net change of up by 3.93Mn shares quarter on quarter, and up 14.06Mn shares year over year.
• VANGUARD GROUP INC continues to be the largest institutional holder of Niagen Bioscience as of September 30, 2025, with a position of 4.02Mn shares, representing 5.04% of the company's outstanding stock.
• Among the most significant buyers of Niagen Bioscience during September 2025 were UBS Group AG (1.11Mn), MILLENNIUM MANAGEMENT LLC (652.68K), ALGERT GLOBAL LLC (446.83K), CHARLES SCHWAB INVESTMENT MANAGEMENT INC (414.73K), DIMENSIONAL FUND ADVISORS LP (382.82K).
• Leading sellers of Niagen Bioscience stock in September 2025 included D. E. Shaw & Co., Inc. (1.06Mn), Invesco Ltd. (433.26K), JANUS HENDERSON GROUP PLC (304.67K), Connor, Clark & Lunn Investment Management Ltd. (195.45K), LAZARD ASSET MANAGEMENT LLC (189.45K).
• The top 10 institutional holders of Niagen Bioscience for the quarter ending September 2025 included VANGUARD GROUP INC (4.02Mn), BlackRock, Inc. (3.98Mn), Tieton Capital Management, LLC (1.65Mn), ARROWSTREET CAPITAL, LIMITED PARTNERSHIP (1.44Mn), GEODE CAPITAL MANAGEMENT, LLC (1.30Mn), UBS Group AG (1.20Mn), STATE STREET CORP (1.09Mn), Qube Research & Technologies Ltd (876.23K), Nuveen, LLC (790.90K), MILLENNIUM MANAGEMENT LLC (774.24K).